Methods of identifying and treating individuals exhibiting mutant kit protein

Details for Australian Patent Application No. 2006257919 (hide)

Owner The United States of America as Represented by The Department of Veteran Affairs Oregon Health and Science University Bristol-Myers Squibb Company

Inventors Lee, Francis Y.; Heinrich, Michael C.

Agent Cullen & Co

Pub. Number AU-A-2006257919

PCT Pub. Number WO2006/135790

Priority 60/748,418 08.12.05 US; 60/736,668 15.11.05 US; 60/689,113 09.06.05 US

Filing date 9 June 2006

Wipo publication date 21 December 2006

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/135790 Priority application(s): WO2006/135790

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257924-Imidazoand triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type I

2006257915-Methods for synthesis of encoded libraries